Versuchen GOLD - Frei
GlaxoSmithKline Q3 profit rises 29%
Mint New Delhi
|February 10, 2026
GlaxoSmithKline Pharmaceuticals on Monday posted 29% increase in consolidated profit after tax at ₹296 crore for the third quarter ended 31 December 2025.
-
The drugmaker reported a profit after tax of ₹230 crore for the October-December period of last fiscal. Revenue from operations rose to ₹1,041 crore from ₹949 crore in the year-ago
Diese Geschichte stammt aus der February 10, 2026-Ausgabe von Mint New Delhi.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint New Delhi
Mint New Delhi
When Al becomes your personal trainer
As fitness enthusiasts turn to artificial intelligence for workout plans and marathon prep, experts weigh in on its effectiveness
4 mins
February 10, 2026
Mint New Delhi
Bajaj Electricals Q3 loss at ₹34.1 cr
Bajaj Electricals Ltd on Monday reported a consolidated net loss of ₹34.10 crore for the September quarter of FY26 due to contraction in gross margin and impact from new labour codes.
1 min
February 10, 2026
Mint New Delhi
Bandhan’s Ghosh bats for longer bank CEO tenures
Ghosh stepped down as managing director and chief executive of Bandhan Bank in July 2024.
2 mins
February 10, 2026
Mint New Delhi
PE giants eye $1 bn deal for EQT's 40% CitiusTech stake
CitiusTech posted revenue of ₹3,552 cr and profit of ₹350 cr, as growth moves into mid-teens
2 mins
February 10, 2026
Mint New Delhi
THE 18% EDGE: SET FOR BULL RUN 2.0?
Fiscal discipline and trade breakthroughs have now created prime entry points for equity investors
7 mins
February 10, 2026
Mint New Delhi
Novo Nordisk says it’s suing Hims to halt obesity drug copycats
Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knockoff of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill.
2 mins
February 10, 2026
Mint New Delhi
The Chinese ‘auntie’ investors behind the gold and silver frenzy
Rose Tian is worried about the economy and global instability.
2 mins
February 10, 2026
Mint New Delhi
GlaxoSmithKline Q3 profit rises 29%
GlaxoSmithKline Pharmaceuticals on Monday posted 29% increase in consolidated profit after tax at ₹296 crore for the third quarter ended 31 December 2025.
1 min
February 10, 2026
Mint New Delhi
How demat MFs will get automated SWP
The Securities and Exchange Board of India (Sebi) has proposed extending the facility of standing instructions for systematic withdrawal plans (SWP) and systematic transfer plans (STP) to mutual fund units held in demat form, a move that could simplify cash flow planning for investors.
2 mins
February 10, 2026
Mint New Delhi
SBI Q3 aided by non-core gains
State Bank of India’s (SBI) Q3FY26 results landed strongly on Saturday against a slightly jittery backdrop.
2 mins
February 10, 2026
Listen
Translate
Change font size